肝靶向纳米给药系统的最新研究进展
|
摘要
肝脏疾病是威胁人类生命健康的重要疾病之一,对肝脏疾病检测及治疗方法的研究也引起人们的极大重视。靶向药物递送系统(TDDS)可将药物选择性地输送到靶点组织,从而提高药物的生物利用率并降低毒副作用,已引起了研究者的广泛关注。近年来,越来越多的研究尝试将靶向药物递送系统应用于肝脏疾病的显像检测以及药物/基因治疗,并取得了十分显著的成绩。本文将对近年来开发的新型纳米肝靶向给药系统,尤其是配体-受体介导的主动肝靶向给药系统在药物/基因递送以及显影检测方面的最新进展做一个综述,对各靶向给药系统的肝靶向能力进行了总结对比,并对肝靶向给药系统的发展方向进行了预测。
Liver disease is one of the most serious deseases which pose significant health challenge worldwide.Advances in treatment,detection,surgical techniques have resulted in considerable improvements in therapy of liver disease.It has aroused extensive attention of researchers that targeted drug delivery system can delivery the drug selectively to the target tissue,thereby improving the bioavailability of the drug and reduce its side effects.In recent years,increasing researchers have attempted to apply targeted drug delivery system(TDDS)to the imaging detection of the liver disease and drug/gene therapy,and achieved significant results.This review addresses the latest development of the liver TDDS in recent years,especially the ligand/receptor-mediated liver TDDS in drug/gene delivery or imaging detection;summarize the liver targeting ability of different TDDS,and then discusses the challenges and future perspectives for the development of liver TDDS.
Liver disease is one of the most serious deseases which pose significant health challenge worldwide.Advances in treatment,detection,surgical techniques have resulted in considerable improvements in therapy of liver disease.It has aroused extensive attention of researchers that targeted drug delivery system can delivery the drug selectively to the target tissue,thereby improving the bioavailability of the drug and reduce its side effects.In recent years,increasing researchers have attempted to apply targeted drug delivery system(TDDS)to the imaging detection of the liver disease and drug/gene therapy,and achieved significant results.This review addresses the latest development of the liver TDDS in recent years,especially the ligand/receptor-mediated liver TDDS in drug/gene delivery or imaging detection;summarize the liver targeting ability of different TDDS,and then discusses the challenges and future perspectives for the development of liver TDDS.
引文
[1]搜狐健康http://health.sohu.com/s2012/shijieganyanri/.
[2]Arii S,Yamaoka Y,Futagawa S,Futagawa S,Inoue K,Kobayashi K,Kojiro M,Makuuchi M,Nakamura Y,Okita K,YamadaR.Hepatology,2000,32(6):1224～1229.
[3]Lencioni R,Cioni D,Crocetti L,Franchini C,Pina C D,Lera J,Bartolozzi C.Radiology,2005,234(3):961～967.
[4]Hussain N.Adv Drug Deliv Rev,2000,43:95～100.
[5]Damon S,Norased N,Elvin B,Jinming G.Pharm Res,2007,24(6):1029～1046.
[6]Gaumet M,Vargas A,Gurny R,Delie F.Eur J Pharm Sci,2008,69:1～9.
[7]Holgado M A,Martín-Banderas L,lvarez-Fuentes J,Fernandez-Arevalo M,Arias J L.Curr Med Chem,2012,19:3188～3195.
[8]Chiannilkulchai N,Ammourl N,Caillou B,Devissaguet J P,Couvreur P.Cancer Chemoth Pharm,1990,26:122～126.
[9]Chiannilkulchai N,Driouich Z,Benoit J P,Parodi A L,Couvreur P.Select Cancer Ther,1989,5(1):1～11.
[10]Maruyama K.Adv Drug Deliv Rev,2011,63:161～169.
[11]Popielarski S R,Hu-Lieskovan S,French S W,Triche T J,Davis M E.Bioconjugate Chem,2005,16:1071～80.
[12]Ashwell G,Morella A G.Adv Enzymol Relat Areas Mol Biol,1974,41:99～128.
[13]Schwartz A L,Rup D,Lodish H F,J Biol Chem,1980,255(19):9033～9036.
[14]Schwartz A L,Fridovich S E,Lodish H F.J Biol Chem,1982,257(8):4230～4237.
[15]Kim E M,Jeong H J,Kim S L,Sohn M H,Nah J W,Bom H S,Park I K,Cho C S.Nucl Med Biol,2006,33(4):529～534.
[16]Wu J,Liu P,Zhu J L.Hepatology,1998,27(3):772～778.
[17]Cai G M,Jiang M J,Zhang B,Zhou Y Y,Zhang L F,Lei J Y,Gu X B,Cao G X,Jin J,Zhang R J.Biol Pharm Bull,2009,32(3):440～443.
[18]Liang H F,Yang T F,Huang C T,Chen M C,Sung H W.J Control Release,2005,105:213～225.
[19]Sung H W,Liang H F,Tu H,United States Patent.Patent No.US 7,348,030B1.
[20]Liang H F,Chen S C,Chen M C,Lee P W,Chen C T,Sung H W.Bioconjugate Chem,2006,17:291～299.
[21]Liang H Fa,Chen C T,Chen S C,Kulkarni A R,Chiu Y L,Chen C M,Sung H W.Biomaterials,2006,27:2051～2059.
[22]Mi F L,Yu S H,Peng C K,Sung H W,Shyu S S,Liang H F,Huang M F,Wang C C.Polymer,2006,47(12):4348～4358.
[23]Jeong Y I,Seo S J,Park I K,Lee H C,Kang I C,Akaike T,Cho C S.Int J Pharm,2005,296:151～161.
[24]Wu D Q,Lu B,Chang C,Chen C S,Wang T,Zhang Y Y,Cheng S X,Jiang X J,Zhang X Z,Zhuo R X.Biomaterials,2009,30:1363～1371.
[25]Ma P A,Liu S,Huang Y B,Chen X S,Zhang L P,Jing X B.Biomaterials,2010,31(9):2646～2654.
[26]Maitani Y,Kawano K,Yamado K,Nagai T,Takayama K.J Control Release,2001;75:381～389.
[27]Kawano K,Nakamura K,Hayashi K,Nagai T,Takayama K,Maitani Y.Biol Pharm Bull,2002,25(6):766～770.
[28]Shi J,Yan W W,Qi X R,Yang L,Zhang L.Acta Pharmaceutica Sinica,2004,39(7):551～555.
[29]Fiore C,Eisenhut M,Krausse R,Ragazzi E,Pellati D,Armanini D,Bielenberg J.Phytother Res,2008,22(2):141～148.
[30]Asl MN,Hosseinzadeh H.,Phytother Res,2008,22(6):709～724.
[31]Negoshi M,Irie A,Nagata N,Ichikawa A.Biochim Biophys Acta-Biomembr,1991,1066(1):77～82.
[32]Ishada S,Sakaya Y,Ichikawa T,Taira Z.Biol Pharm Bull,1993,16(3):293～297.
[33]杨山麦,周方成,顾云娣,刘水腾,蒋小玲,成令忠.中华肝脏病杂志,1999,7(S1):27～29.
[34]Tsuji H,Osaka S,Kiwada H.Chem Pharm Bull,1991,39(4):1004～1008.
[35]Osaka S,Tsuji H,Kiwada H.Biol Pharm Bull,1994,17(7):940～943.
[36]Mao S J,Hou S X,He R,Zhang L K,Wei D P,Bi Y Q,Jin H.World J Gastroenterol,2005,11(20):3075～3079.
[37]Lin A H,Liu Y,Huang Y,Sun J,Wu Z F,Zhang X,Ping Q N.Int J Pharm,2008,359(1～2):247～253.
[38]Lin A H,Chen J,Liu Y M,Deng S G,Wu Z F,Huang Y,Ping Q N.,Drug Dev Ind Pharm,2009,35(11):1348～1355.
[39]Mao S J,Bi Y Q,Jin H,Wei D P,He R,Hou S X.Pharmazie,2007,62:614～619.
[40]Cha R T,Du T,Li JH,Yuan Z.Polym Int,2006,55(9):1057～1062.
[41]查瑞涛,贺晓婷,杜田,袁直.高等学校化学学报,2007,28(6):1098～1100.
[42]Huang W,Wang W,Wang P,Tian Q,Zhang C N,Wang C H,Yuan Z,Liu M,Wan H Y,Tang H.Acta Biomater,2010,6(10):3927～3935.
[43]He Z Y,Zheng X,Wu X H,Song X R,He G,Wu W F,Yu S,Mao S J,Wei Y Q.Int J Pharm,2010,397(1～2):147～154.
[44]Tian Q,Zhang C N,Wang X H,Wang W,Cha R T,Wang J H,Yuan Z,Liu M,Wan H Y,Tang H.Biomaterials,2010,31:4748～4756.
[45]吴超,郭伟英.辽宁医学学报,2008,29(6):490～493.
[46]Tian Q,Wang X H,Wang W,Zhang C N.Int J Pharmac,2010,400(1～2):153～157.
[47]Zhang C N,Wang W,Liu T,Wu Y K.Biomaterials,2012,33(7):2187～2196.
[48]Tian Q,Wang X H,Wang W,Zhang C N,Wang P,Yuan Z.Nanomed-Nanotechnol,2012,8(6):870～879.
[49]Lack L.Environ Health Persp,1979,33:79～90.
[50]Chen J P,Zhu J B,Chen H X.,Drug Dev Ind Pharm,2010;36(6):657～665.
[51]Lee H,Kim S,Shin D,Yoon Y,Choi T H,Cheon G J,Kim M.Biochem Bioph Res Co,2009,378(2):192～196.
[52]Rui M,Guo W,Ding Q,Wei X,Xu J,Xu Y.Int J Nanomed,2012,7:3751～3768.
[53]Stockert R J,Morell A G.Hepatology,1983,3:750～757.
[54]Sawamura T,Nakada H,Hazama H.Gastroenterology,1984,87(5):1217～1221.
[55]Schouten D,Kooij M,Muller J,Pieters M N,Bijsterbosch M K,Berkel T J.Mol Pharmacol,1993,44(2):486～492.
[56]Bijsterbosch M K,Van De Bilt H,Van Berkel T J C.Biochem Pharmacol,1996,52(1):113～121.
[57]Wu J,Nantz M H,Zern M A.Front Biosci,2002,7:717～725.
[58]Beljaars L,Olinga P,Molema G,Bleser P D,Geerts A,Groothuis G M M,Meijer D K F,Poelstra K.Liver,2001:21:320～328.
[59]张志荣主编.靶向治疗分子基础与靶向药物设计,北京,科学出版社,2005:127～128.
[60]Lee S J,Zheng N Y,Clavijo M,Nussenzweig M C.Infect Immun,2003,71(1):437～445.
[61]Hirata K,Maruyama T,Watanabe H,Maeda H,Nakajou K,Iwao Y,Ishima Y,Katsumi H,Hashida M,Otagiri M.J ControlRelease,145(2010)9～16.
[62]Bijsterbosh M K,Donker W,Bilt H V D,Weely S V,Berkel T J C V,Aerts J M F G.Eur J Biochem,1996,237:344～349.
[63]Yeeprae W,Kawakami S,Yamashita F,Hashida M.J Control Release,2006,114:193～201.
[64]Un K,Kawakami S,Suzuki R,Maruyama K,Yamashita F,Hashida M.Biomaterials,2010,31,7813～7826.
[65]Un K,Kawakami S,Higuchi Y,Suzuki R,Maruyama K,Yamashita F,Hashida M.J Control Release,2011,156,355～363.
[66]Yang N,Ye Z,Li F,Mahato R I.Bioconjugate Chem,2009,20,213～221.
[67]Prakash J,Beljaars L,Harapanahalli A K,Zeinstra-Smith M,Jager-Krikken A d,Hessing M,Steen H,Poelstra K.Int J Cancer,2010,126,1966～1981.
[68]Beljaars L,Molema G,Schuppan D,Geerts A,Bleser P J D,Weert B,Meijer D K F,Poelstra,J Biol Chem,2000,275:12743～12751.
[69]Du S L,Pan H,Lu W Y,Wang J,Wu J,Wang J Y.J Pharmacol Exp Ther,2007,322:560～568.
[70]Li F,Sun J Y,Wang J Y,Du S L,Lu W Y,Liu M,Xie C,Shi J Y.J Control Release,2008,131(1):77～82.
[71]Oh E J,Park K,Kim K S,Kim J,Yang J,Kong J,Lee M Y,Hoffman A S,Hahn S K.J Control Release,2010(1),141,2～12.
[72]Ohya Y,Takeda S,Shibata Y,Ouchi T,Kano A,Iwata T,Mochizuki S,Taniwaki T,Maruyama A.J Control Release,2011,155(1):104～110.
[73]Toriyabe N,Hayashi Y,Hyodo M,Harashima H.Biol Pharm Bull,2011,34(7):1084～1089.
[74]Kim K S,Hur W,Park S J,Hong S W,Choi E C,Goh E J,Yoon S K.Hahn S K,ACS Nano,2010,4(6):3005～3014.
[75]Goh E J,Kim K S,Kim Y R,Jung H S,Beack S,Kong W H,Scarcelli G,Yun S H,Hahn S K.Biomacromolecules,2012,13:2554～2561.
[76]Li Q H,Yan Z Q,Li F,Lu W Y,Wang J Y,Guo C Y.Nanotechnology,2012,23(26):265101.
[77]Bansal R,Prakash J,Ruijter M,Beljaars L,Poelstra K.Mol Pharm,2011,8(5):1899～1909.
[78]Beljaars L,Weerta B,Geerts A,Meijer D K F,Poelstra K.Biochem Pharm,2003,66(7):1307～1317.
[79]Li F,Li Q H,Wang J Y,Zhan C Y,Xie C,Lu W Y.J Controlled Release,2012,159(2):261～270.
[80]李云春,谭天秩,莫廷树,卢武胜,邓侯富,杨晓川,李霄.生物医学工程学杂志,2007,24(4):857～861.
[81]马骏,王建华,刘嵘,钱晟,陈颐,石洪成,顾宇参.中华核医学杂志,2009,29(5):343～347.
[82]Haraguchi N,Ishii H,Mimori K,Tanaka F,Ohkuma M,Kim H M,Akita H,Takiuchi D,Hatano H,Nagano H,Barnard G F,Doki Y,Mori M.J Clin Invest,2010;120(9):3326～3339.
[83]Lapalombella R,Zhao X B,Triantafillou G,Yu B,Jin Y,LoNAKI g,Cheney C,Heerema N,Jarjoura D,Lehman A,Lee L J,Macucci G,Lee R J,Caligiuri M A,Muthusamy N,Byrd J C.Clin Caner Res,2008,14(2):569～578.
[84]Wang L N,Su W J,Liu Z,Zhou M Q,Chen Y N,Lu D,Liu Y H,Fan Y,Zheng Y Z,Han Z C,Kong D L,Wu J C,Xiang R,Li Z J.Biomaterials 2012,33(20):5107～5114.
[85]陈志南,刑金良.中国生物技术产业发展报告,北京:化学工业出版社,2003,107.
[86]Ross J S,Schenkein D P,Pietrusko R,Rolfe M,Linette G P,Stec James,Stagliano N E,Ginsburg G S,Symmans W F,PusztaiL,Hortobagyi G N.Amer J Clin Path,2004,122(4):598～609.
[87]Koontz J W,Iwahashi M.Science,1981,211(4485):947～949.
[88]Kurtaran A.,Li S R,Raderer M,Leimer M,Müller C,Pidlich J,Neuhold N,Hübsch P,Angelberger P,Scheithauer W,Virgolini I.J Nucl Med,1995,36(10):1875～1881.
[89]欧晓红,匡安仁,梁正路,王朝俊.同位素,2001,14(2):76～80.
[90]Liu W S,Huang Y,Zhang Z R.Arch Pharm Res,2003,26(11):892～897.
[91]Ou X H,Kuang A R,Peng X,Zhong Y G.World J Gastroenterol,2003,9(8):1675～1678.
[92]黄娟.以胰岛素为多药载体的肿瘤主动靶向给药系统研究,四川,四川大学,2007.
[93]毕文祥,张培海,许松德,胡晓燕,李蕾.山东医科大学学报,1999,37(2):94～96.
[94]Chang J E,Shim W S,Yang S G,Kwak E Y,Chong S,Kim D D,Chung S J,Shim C K.Pharm Res,2012,29:795～805.
[95]Lee Y L,Ahn B C,Lee Y,Lee S W,Cho J Y,Lee J.J Pept Sci,2011,17(11):763～769.
[96]Du B,Qian M,Zhou Z L,Wang P,Wang L,Zhang X P,Wu M,Zhang P,Mei B.Biochem Bioph Res Co,2006,342(3):956～962.
[97]Gan Z F,Jiang J S,Yang Y,Du B,Qian M,Zhang P.J Biomed Mater Res A,2007,84A(1):10～18.
[98]Jiang J S,Gan Z F,Yang Y,Du B,Qian M,Zhang P.J Nanopart Res,2009,11:1321～1330.
[99]Yang Y,Jiang J S,Du B,Gan Z F,Qian M,Zhang P.J Mater Sci-Mater M,2009,20:301～307.
[100]Hong G B,Yuan R X,Liang B L,Shen J,Yang X Q,Shuai X T.Biomed Microdevices,2008,10:693～700.
[101]Wang W,Zhou F,Ge L,Liu X,Kong F.Int J Nanomed,2012,7:2513～2522.
[102]Ma M,Yuan Z F,Chen X J,Li F,Zhuo R X.Acta Biomaterialia,2012,8(2):599～607.
[103]Danhier F,Vroman B,Lecouturier N,Crokart N,Pourcelle V,Freichels H,Jérme C,Marchand-Brynaert J,Feron O,Préat V.J Control Release,2009,140(2):166～173.
[104]Shokeen M.,Pressly E D,Hagooly A,Zheleznyak A,Ramos N,Fiamengo A L,WelchM J,Hawker C J,Anderson C J.ACSNano,2011,5:738～747.
[105]Kolhatkar R,Lote A,Khambhati H.Current Drug Discovery Technologies,2011,8(3):197～206.
[2]Arii S,Yamaoka Y,Futagawa S,Futagawa S,Inoue K,Kobayashi K,Kojiro M,Makuuchi M,Nakamura Y,Okita K,YamadaR.Hepatology,2000,32(6):1224～1229.
[3]Lencioni R,Cioni D,Crocetti L,Franchini C,Pina C D,Lera J,Bartolozzi C.Radiology,2005,234(3):961～967.
[4]Hussain N.Adv Drug Deliv Rev,2000,43:95～100.
[5]Damon S,Norased N,Elvin B,Jinming G.Pharm Res,2007,24(6):1029～1046.
[6]Gaumet M,Vargas A,Gurny R,Delie F.Eur J Pharm Sci,2008,69:1～9.
[7]Holgado M A,Martín-Banderas L,lvarez-Fuentes J,Fernandez-Arevalo M,Arias J L.Curr Med Chem,2012,19:3188～3195.
[8]Chiannilkulchai N,Ammourl N,Caillou B,Devissaguet J P,Couvreur P.Cancer Chemoth Pharm,1990,26:122～126.
[9]Chiannilkulchai N,Driouich Z,Benoit J P,Parodi A L,Couvreur P.Select Cancer Ther,1989,5(1):1～11.
[10]Maruyama K.Adv Drug Deliv Rev,2011,63:161～169.
[11]Popielarski S R,Hu-Lieskovan S,French S W,Triche T J,Davis M E.Bioconjugate Chem,2005,16:1071～80.
[12]Ashwell G,Morella A G.Adv Enzymol Relat Areas Mol Biol,1974,41:99～128.
[13]Schwartz A L,Rup D,Lodish H F,J Biol Chem,1980,255(19):9033～9036.
[14]Schwartz A L,Fridovich S E,Lodish H F.J Biol Chem,1982,257(8):4230～4237.
[15]Kim E M,Jeong H J,Kim S L,Sohn M H,Nah J W,Bom H S,Park I K,Cho C S.Nucl Med Biol,2006,33(4):529～534.
[16]Wu J,Liu P,Zhu J L.Hepatology,1998,27(3):772～778.
[17]Cai G M,Jiang M J,Zhang B,Zhou Y Y,Zhang L F,Lei J Y,Gu X B,Cao G X,Jin J,Zhang R J.Biol Pharm Bull,2009,32(3):440～443.
[18]Liang H F,Yang T F,Huang C T,Chen M C,Sung H W.J Control Release,2005,105:213～225.
[19]Sung H W,Liang H F,Tu H,United States Patent.Patent No.US 7,348,030B1.
[20]Liang H F,Chen S C,Chen M C,Lee P W,Chen C T,Sung H W.Bioconjugate Chem,2006,17:291～299.
[21]Liang H Fa,Chen C T,Chen S C,Kulkarni A R,Chiu Y L,Chen C M,Sung H W.Biomaterials,2006,27:2051～2059.
[22]Mi F L,Yu S H,Peng C K,Sung H W,Shyu S S,Liang H F,Huang M F,Wang C C.Polymer,2006,47(12):4348～4358.
[23]Jeong Y I,Seo S J,Park I K,Lee H C,Kang I C,Akaike T,Cho C S.Int J Pharm,2005,296:151～161.
[24]Wu D Q,Lu B,Chang C,Chen C S,Wang T,Zhang Y Y,Cheng S X,Jiang X J,Zhang X Z,Zhuo R X.Biomaterials,2009,30:1363～1371.
[25]Ma P A,Liu S,Huang Y B,Chen X S,Zhang L P,Jing X B.Biomaterials,2010,31(9):2646～2654.
[26]Maitani Y,Kawano K,Yamado K,Nagai T,Takayama K.J Control Release,2001;75:381～389.
[27]Kawano K,Nakamura K,Hayashi K,Nagai T,Takayama K,Maitani Y.Biol Pharm Bull,2002,25(6):766～770.
[28]Shi J,Yan W W,Qi X R,Yang L,Zhang L.Acta Pharmaceutica Sinica,2004,39(7):551～555.
[29]Fiore C,Eisenhut M,Krausse R,Ragazzi E,Pellati D,Armanini D,Bielenberg J.Phytother Res,2008,22(2):141～148.
[30]Asl MN,Hosseinzadeh H.,Phytother Res,2008,22(6):709～724.
[31]Negoshi M,Irie A,Nagata N,Ichikawa A.Biochim Biophys Acta-Biomembr,1991,1066(1):77～82.
[32]Ishada S,Sakaya Y,Ichikawa T,Taira Z.Biol Pharm Bull,1993,16(3):293～297.
[33]杨山麦,周方成,顾云娣,刘水腾,蒋小玲,成令忠.中华肝脏病杂志,1999,7(S1):27～29.
[34]Tsuji H,Osaka S,Kiwada H.Chem Pharm Bull,1991,39(4):1004～1008.
[35]Osaka S,Tsuji H,Kiwada H.Biol Pharm Bull,1994,17(7):940～943.
[36]Mao S J,Hou S X,He R,Zhang L K,Wei D P,Bi Y Q,Jin H.World J Gastroenterol,2005,11(20):3075～3079.
[37]Lin A H,Liu Y,Huang Y,Sun J,Wu Z F,Zhang X,Ping Q N.Int J Pharm,2008,359(1～2):247～253.
[38]Lin A H,Chen J,Liu Y M,Deng S G,Wu Z F,Huang Y,Ping Q N.,Drug Dev Ind Pharm,2009,35(11):1348～1355.
[39]Mao S J,Bi Y Q,Jin H,Wei D P,He R,Hou S X.Pharmazie,2007,62:614～619.
[40]Cha R T,Du T,Li JH,Yuan Z.Polym Int,2006,55(9):1057～1062.
[41]查瑞涛,贺晓婷,杜田,袁直.高等学校化学学报,2007,28(6):1098～1100.
[42]Huang W,Wang W,Wang P,Tian Q,Zhang C N,Wang C H,Yuan Z,Liu M,Wan H Y,Tang H.Acta Biomater,2010,6(10):3927～3935.
[43]He Z Y,Zheng X,Wu X H,Song X R,He G,Wu W F,Yu S,Mao S J,Wei Y Q.Int J Pharm,2010,397(1～2):147～154.
[44]Tian Q,Zhang C N,Wang X H,Wang W,Cha R T,Wang J H,Yuan Z,Liu M,Wan H Y,Tang H.Biomaterials,2010,31:4748～4756.
[45]吴超,郭伟英.辽宁医学学报,2008,29(6):490～493.
[46]Tian Q,Wang X H,Wang W,Zhang C N.Int J Pharmac,2010,400(1～2):153～157.
[47]Zhang C N,Wang W,Liu T,Wu Y K.Biomaterials,2012,33(7):2187～2196.
[48]Tian Q,Wang X H,Wang W,Zhang C N,Wang P,Yuan Z.Nanomed-Nanotechnol,2012,8(6):870～879.
[49]Lack L.Environ Health Persp,1979,33:79～90.
[50]Chen J P,Zhu J B,Chen H X.,Drug Dev Ind Pharm,2010;36(6):657～665.
[51]Lee H,Kim S,Shin D,Yoon Y,Choi T H,Cheon G J,Kim M.Biochem Bioph Res Co,2009,378(2):192～196.
[52]Rui M,Guo W,Ding Q,Wei X,Xu J,Xu Y.Int J Nanomed,2012,7:3751～3768.
[53]Stockert R J,Morell A G.Hepatology,1983,3:750～757.
[54]Sawamura T,Nakada H,Hazama H.Gastroenterology,1984,87(5):1217～1221.
[55]Schouten D,Kooij M,Muller J,Pieters M N,Bijsterbosch M K,Berkel T J.Mol Pharmacol,1993,44(2):486～492.
[56]Bijsterbosch M K,Van De Bilt H,Van Berkel T J C.Biochem Pharmacol,1996,52(1):113～121.
[57]Wu J,Nantz M H,Zern M A.Front Biosci,2002,7:717～725.
[58]Beljaars L,Olinga P,Molema G,Bleser P D,Geerts A,Groothuis G M M,Meijer D K F,Poelstra K.Liver,2001:21:320～328.
[59]张志荣主编.靶向治疗分子基础与靶向药物设计,北京,科学出版社,2005:127～128.
[60]Lee S J,Zheng N Y,Clavijo M,Nussenzweig M C.Infect Immun,2003,71(1):437～445.
[61]Hirata K,Maruyama T,Watanabe H,Maeda H,Nakajou K,Iwao Y,Ishima Y,Katsumi H,Hashida M,Otagiri M.J ControlRelease,145(2010)9～16.
[62]Bijsterbosh M K,Donker W,Bilt H V D,Weely S V,Berkel T J C V,Aerts J M F G.Eur J Biochem,1996,237:344～349.
[63]Yeeprae W,Kawakami S,Yamashita F,Hashida M.J Control Release,2006,114:193～201.
[64]Un K,Kawakami S,Suzuki R,Maruyama K,Yamashita F,Hashida M.Biomaterials,2010,31,7813～7826.
[65]Un K,Kawakami S,Higuchi Y,Suzuki R,Maruyama K,Yamashita F,Hashida M.J Control Release,2011,156,355～363.
[66]Yang N,Ye Z,Li F,Mahato R I.Bioconjugate Chem,2009,20,213～221.
[67]Prakash J,Beljaars L,Harapanahalli A K,Zeinstra-Smith M,Jager-Krikken A d,Hessing M,Steen H,Poelstra K.Int J Cancer,2010,126,1966～1981.
[68]Beljaars L,Molema G,Schuppan D,Geerts A,Bleser P J D,Weert B,Meijer D K F,Poelstra,J Biol Chem,2000,275:12743～12751.
[69]Du S L,Pan H,Lu W Y,Wang J,Wu J,Wang J Y.J Pharmacol Exp Ther,2007,322:560～568.
[70]Li F,Sun J Y,Wang J Y,Du S L,Lu W Y,Liu M,Xie C,Shi J Y.J Control Release,2008,131(1):77～82.
[71]Oh E J,Park K,Kim K S,Kim J,Yang J,Kong J,Lee M Y,Hoffman A S,Hahn S K.J Control Release,2010(1),141,2～12.
[72]Ohya Y,Takeda S,Shibata Y,Ouchi T,Kano A,Iwata T,Mochizuki S,Taniwaki T,Maruyama A.J Control Release,2011,155(1):104～110.
[73]Toriyabe N,Hayashi Y,Hyodo M,Harashima H.Biol Pharm Bull,2011,34(7):1084～1089.
[74]Kim K S,Hur W,Park S J,Hong S W,Choi E C,Goh E J,Yoon S K.Hahn S K,ACS Nano,2010,4(6):3005～3014.
[75]Goh E J,Kim K S,Kim Y R,Jung H S,Beack S,Kong W H,Scarcelli G,Yun S H,Hahn S K.Biomacromolecules,2012,13:2554～2561.
[76]Li Q H,Yan Z Q,Li F,Lu W Y,Wang J Y,Guo C Y.Nanotechnology,2012,23(26):265101.
[77]Bansal R,Prakash J,Ruijter M,Beljaars L,Poelstra K.Mol Pharm,2011,8(5):1899～1909.
[78]Beljaars L,Weerta B,Geerts A,Meijer D K F,Poelstra K.Biochem Pharm,2003,66(7):1307～1317.
[79]Li F,Li Q H,Wang J Y,Zhan C Y,Xie C,Lu W Y.J Controlled Release,2012,159(2):261～270.
[80]李云春,谭天秩,莫廷树,卢武胜,邓侯富,杨晓川,李霄.生物医学工程学杂志,2007,24(4):857～861.
[81]马骏,王建华,刘嵘,钱晟,陈颐,石洪成,顾宇参.中华核医学杂志,2009,29(5):343～347.
[82]Haraguchi N,Ishii H,Mimori K,Tanaka F,Ohkuma M,Kim H M,Akita H,Takiuchi D,Hatano H,Nagano H,Barnard G F,Doki Y,Mori M.J Clin Invest,2010;120(9):3326～3339.
[83]Lapalombella R,Zhao X B,Triantafillou G,Yu B,Jin Y,LoNAKI g,Cheney C,Heerema N,Jarjoura D,Lehman A,Lee L J,Macucci G,Lee R J,Caligiuri M A,Muthusamy N,Byrd J C.Clin Caner Res,2008,14(2):569～578.
[84]Wang L N,Su W J,Liu Z,Zhou M Q,Chen Y N,Lu D,Liu Y H,Fan Y,Zheng Y Z,Han Z C,Kong D L,Wu J C,Xiang R,Li Z J.Biomaterials 2012,33(20):5107～5114.
[85]陈志南,刑金良.中国生物技术产业发展报告,北京:化学工业出版社,2003,107.
[86]Ross J S,Schenkein D P,Pietrusko R,Rolfe M,Linette G P,Stec James,Stagliano N E,Ginsburg G S,Symmans W F,PusztaiL,Hortobagyi G N.Amer J Clin Path,2004,122(4):598～609.
[87]Koontz J W,Iwahashi M.Science,1981,211(4485):947～949.
[88]Kurtaran A.,Li S R,Raderer M,Leimer M,Müller C,Pidlich J,Neuhold N,Hübsch P,Angelberger P,Scheithauer W,Virgolini I.J Nucl Med,1995,36(10):1875～1881.
[89]欧晓红,匡安仁,梁正路,王朝俊.同位素,2001,14(2):76～80.
[90]Liu W S,Huang Y,Zhang Z R.Arch Pharm Res,2003,26(11):892～897.
[91]Ou X H,Kuang A R,Peng X,Zhong Y G.World J Gastroenterol,2003,9(8):1675～1678.
[92]黄娟.以胰岛素为多药载体的肿瘤主动靶向给药系统研究,四川,四川大学,2007.
[93]毕文祥,张培海,许松德,胡晓燕,李蕾.山东医科大学学报,1999,37(2):94～96.
[94]Chang J E,Shim W S,Yang S G,Kwak E Y,Chong S,Kim D D,Chung S J,Shim C K.Pharm Res,2012,29:795～805.
[95]Lee Y L,Ahn B C,Lee Y,Lee S W,Cho J Y,Lee J.J Pept Sci,2011,17(11):763～769.
[96]Du B,Qian M,Zhou Z L,Wang P,Wang L,Zhang X P,Wu M,Zhang P,Mei B.Biochem Bioph Res Co,2006,342(3):956～962.
[97]Gan Z F,Jiang J S,Yang Y,Du B,Qian M,Zhang P.J Biomed Mater Res A,2007,84A(1):10～18.
[98]Jiang J S,Gan Z F,Yang Y,Du B,Qian M,Zhang P.J Nanopart Res,2009,11:1321～1330.
[99]Yang Y,Jiang J S,Du B,Gan Z F,Qian M,Zhang P.J Mater Sci-Mater M,2009,20:301～307.
[100]Hong G B,Yuan R X,Liang B L,Shen J,Yang X Q,Shuai X T.Biomed Microdevices,2008,10:693～700.
[101]Wang W,Zhou F,Ge L,Liu X,Kong F.Int J Nanomed,2012,7:2513～2522.
[102]Ma M,Yuan Z F,Chen X J,Li F,Zhuo R X.Acta Biomaterialia,2012,8(2):599～607.
[103]Danhier F,Vroman B,Lecouturier N,Crokart N,Pourcelle V,Freichels H,Jérme C,Marchand-Brynaert J,Feron O,Préat V.J Control Release,2009,140(2):166～173.
[104]Shokeen M.,Pressly E D,Hagooly A,Zheleznyak A,Ramos N,Fiamengo A L,WelchM J,Hawker C J,Anderson C J.ACSNano,2011,5:738～747.
[105]Kolhatkar R,Lote A,Khambhati H.Current Drug Discovery Technologies,2011,8(3):197～206.